Nationally Subsidized Continuous Glucose Monitoring: A Cost-effectiveness Analysis.

Anthony J Pease Sophia ZoungasEmily CallanderTimothy W JonesStephanie R JohnsonDeborah Jane Holmes-WalkerDavid E BloomElizabeth A Davis Ella Zomer

Published in: Diabetes care (2022)

Providing subsidized access to CGM for people with type 1 diabetes was found to be cost-effective compared with a completely user-funded model in Australia.

Keyphrases